Skip to main content
Clinical Trials/NCT00047996
NCT00047996
Enrolling by Invitation
N/A

Human Specimen Collection to Support Basic and Clinical Research

National Heart, Lung, and Blood Institute (NHLBI)2 sites in 1 country2,000 target enrollmentNovember 4, 2002

Overview

Phase
N/A
Intervention
Group1
Conditions
Sickle Cell Disease
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Enrollment
2000
Locations
2
Primary Endpoint
evaluating the role of nitric oxide, inflammatory mediators, and endothelial function in inflammatory diseases of the vasculature such as sickle cell disease, coronary artery disease, pulmonary vascular or advanced lung disease, malaria, and sep...
Status
Enrolling by Invitation
Last Updated
2 months ago

Overview

Brief Summary

The collection of human specimens from both patients and healthy volunteers is necessary for the development of laboratory assays to further basic and clinical research studies. This protocol defines the purposes for which specimens will be collected and establishes general conditions under which sample collection will be performed.

Detailed Description

The collection of human specimens from both patients and healthy volunteers is necessary for the development of laboratory assays to further basic and clinical research studies. This protocol defines the purposes for which specimens will be collected and establishes general conditions under which sample collection will be performed.

Registry
clinicaltrials.gov
Start Date
November 4, 2002
End Date
TBD
Last Updated
2 months ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • INCLUSION CRITERIA:
  • Males or females of age 18 years and older can be included in the study.

Exclusion Criteria

  • Individuals without sickle cell disease or other chronic anemias who wish to donate blood will be excluded if the hemoglobin is less than 10 g/dL for women or less than 12g/dL for men.
  • Individuals with sickle cell disease or other chronic anemias will be excluded from donating blood samples if the hemoglobin is less than 6 g/dL.
  • A participant s most recent CBC result, obtained in the past 12 months, will be used to determine eligibility.
  • There are no exclusion criteria for participants donating urine.

Arms & Interventions

Group1

Clinical Center Patients, Healthy Volunteers

Outcomes

Primary Outcomes

evaluating the role of nitric oxide, inflammatory mediators, and endothelial function in inflammatory diseases of the vasculature such as sickle cell disease, coronary artery disease, pulmonary vascular or advanced lung disease, malaria, and sep...

Study Sites (2)

Loading locations...

Similar Trials